Wednesday, May 11, 2022 9:35:35 AM
1. Management’s obligation is to maximize shareholder value
2. Here that obligation happily is wholly consistent with meeting the moral goals of management and our research partners because share price increases allow (pre-approved products) continued operations - preferably without toxic borrowing.
3. The biggest chance the Company ever had and likely ever will have to impress upon the financial community the importance of its technology was, I am sorry to say, yesterday. “First Impressions.” “Control the narrative.” “Momentum.” “Long-awaited and Earthshaking” results. Any way I am able to think about it yesterday was the day. No “do-overs” in real life - yesterday my friends was real life not “Ferraris.” Mike Tyson - the boxer - I think said, “Everyone has a plan until they get punched in the face.”
4. The narrative, instead, is about a catastrophic SP decline. Instead of a world-improving treatment breakthrough.
5. The market has graded management’s management of the entire situation: F minus. Show me a similar situation where a publicly-traded enterprise has truly “earthshaking” POSITIVE information to disclose and where the share price plummets 80% or whatever. Seriously- give me another example. Even close. Especially where the company has for months at least, had that information available and been able to PLAN a disclosure THAT RESULTED IN MAXIMAL SHAREHOLDER VALUE.
6. So now instead of a series of PRs coming on an orderly-market share price of say even $2.00, we’re all and management had freaking better be in Full Recovery Mode to overcome the FINANCIAL news that inevitably carries the message that the trial was a failure. That’s the public legacy of what happened. What non-follower of iHub is going to believe that a medical breakthrough happened when the stock lost 60% of its value? Ppl on THIS blog don’t all understand that. “How stupid do you think I am?” will be the obvious question of the retail investor that must be answered - with a very long explanation that few will believe.
7. And retail investors are the target market bc management has made it clear they don’t plan to sell, and institutional investor aren’t touching NWBO with the proverbial 10-foot pole. Tho BEFORE yesterday some had some reasonable hope of stable share price above a penny stock, uplisting, and what might have followed.
8. Yesterday was a financial event that management mistook as a scientific event. The cognoscenti were reading ahead to get to the right presentation slide. THE PEOPLE WHO CARED ABOUT SHARE PRICE WERE MAKING MILLIONS, STEALING SHARES FROM INNOCENT LONG INVESTORS WHO DID THE RIGHT THING BY BUYING IN ADVANCE AND HOLDING, and generally, RUNNING RINGS AROUND MANAGEMENT AND THEREBY SERIOUSLY DAMAGING THE COMPANY AND ITS ABILITY TO OPERATE WITHOUT CONTINUALLY LOOKING TO BORROW MONEY.
9. We who were sickened by yesterday but held on will recover some but never all lost value. Not to mention the real emotional trauma and disappointment. Those who were railroaded, never backed by management, and sold, will not.
F MINUS
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM